NCCN Guidelines Add ctDNA-MRD Testing Recommendation for B-Cell Lymphoma
Foresight Diagnostics’ ctDNA-MRD testing has been included in the NCCN Clinical Practice Guidelines for diffuse large B-cell lymphoma.
Read MorePosted by Andy Lundin | Jan 16, 2025 | Lymphoma, Molecular Diagnostics |
Foresight Diagnostics’ ctDNA-MRD testing has been included in the NCCN Clinical Practice Guidelines for diffuse large B-cell lymphoma.
Read MorePosted by Andy Lundin | Jan 14, 2025 | Allergy & Autoimmune, Immunoassay Reagents & test Kits |
Werfen’s Aptiva APS IgG and IgM Reagents for antiphospholipid syndrome (APS) diagnosis address a need in autoimmune disease diagnostics.
Read MorePosted by Andy Lundin | Jan 10, 2025 | Diagnostic Technologies, Sepsis |
The procalcitonin biomarker to guide antibiotic treatment in hospitalized children does not shorten intravenous antibiotic duration compared.
Read MorePosted by Andy Lundin | Jan 6, 2025 | Accreditation |
2024 CAP Laboratory Accreditation Program checklists integrate key CLIA final rule changes, revised personnel requirements, and more.
Read MorePosted by Andy Lundin | Jan 3, 2025 | Molecular Diagnostics |
A novel PCR-based method using CrAss-like phages as microbial source tracking markers can detect human fecal contamination in water.
Read More